Generic Peptides 5-Amino-1MQ 10 and 50 mg NNMT Inhibitor

Generic Peptides 5-Amino-1MQ - 10 and 50 mg Research Vials

Generic Peptides 5-Amino-1MQ is 5-amino-1-methylquinolinium, a small synthetic molecule supplied as a lyophilized powder in 10 mg and 50 mg vials. It sits in the peptide line because of how the catalogue is grouped, but chemically it is not a peptide: it is a quinolinium salt studied as an inhibitor of nicotinamide N-methyltransferase, an enzyme linked to fat-cell metabolism. Buy 5-Amino-1MQ for metabolic research, and treat the label as a research reagent rather than a medicine.

• Two vial sizes - 10 mg and 50 mg
• Small molecule, NNMT inhibitor, not a peptide
• Lyophilized powder, needs bacteriostatic water
• GMP-made, HPLC-verified, COA on file

Variant Comparison

Both vials hold the same compound and differ only in the amount of powder.

At 10 mg in 1 mL the mix reads 10 mg/mL, so 10 units on a U-100 syringe is 1 mg; the 50 mg vial in 5 mL matches that concentration, and in 10 mL it halves to 5 mg/mL, where the same draw is 500 mcg. Metabolic designs usually set the compound beside an energy-sensing agent such as AICAR or the cofactor NAD+, and in fat-mass work the comparator arm is often AOD-9604.

How 5-Amino-1MQ Works

Nicotinamide N-methyltransferase, or NNMT, consumes the methyl donor SAM to break down nicotinamide, and it is over-expressed in adipose tissue in several metabolic models. 5-Amino-1-methylquinolinium is described as an inhibitor of that enzyme. There is no human pharmacokinetic profile, and animal work has used 32 mg/kg subcutaneously once daily; those mouse figures are not a human dose and are given here only as a record of what has been published. Because the enzyme consumes a methyl donor, long-term inhibition raises a theoretical question about methylation balance that the sources describe as described in models but not characterised in people.

Reconstitution & Storage

Add bacteriostatic water down the vial wall and swirl; do not shake. Keep the sealed powder at 2-8 C, away from light, and the mixed solution at 2-8 C without freezing. As a small molecule the compound is usually more stable in solution than a peptide, but no product-specific stability data are published.

Dosage & Administration

No human dose exists, no regulator has approved the compound, and these vials are research material only. The only amounts in the literature come from rodent studies, so nothing on this page should be read as a protocol. Record every figure as a research reference, and keep a separate group for a comparator such as Semaglutide or Retatrutide if the design also follows an incretin pathway.

For laboratory research only, not for human or veterinary use. Information on this page is educational and does not constitute medical advice. Consult a qualified healthcare professional before handling any compound.

For laboratory research only. Consult a healthcare professional before handling any compound. Amounts shown are research references, not recommended human doses.